Global In Vitro Diagnostic Market Report 2013 - Forecast To 2017

Jan 08, 2014, 14:00 ET from Research and Markets

DUBLIN, January 8, 2014 /PRNewswire/ --

Dublin - Research and Markets ( has announced the addition of the "Global In Vitro Diagnostic Market Report 2013 - Forecast To 2017" report to their offering. 

     (Logo: )

The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, microbiology and finally, the geographical market expansion within emerging countries.

The most important trend witnessed recently in the in vitro diagnostic industry is that of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market. The global in vitro disgnostics market is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017.

In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.

Key Topics Covered: 

1 Introduction 
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology

2 Executive Summary 

3 Market Overview 
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.4 Winning Imperatives
3.5 Burning Issues
3.6 Market Share Analysis
3.7 Supply Chain Analysis
3.8 Pestel Analysis

4 Global In Vitro Diagnostic Market, By Technique

5 Global In Vitro Diagnostic Market, By Product Type
5.1 Introduction
5.2 Instruments
5.3 Reagents
5.4 Data Management System Software/Hardware
5.5 Services

6 Global In Vitro Diagnostic Market, By Application 
6.1 Introduction
6.2 Diabetes
6.3 Infectious Diseases
6.4 Oncology/Cancer
6.5 Cardiology
6.6 Nephrology
6.7 Autoimmune Diseases
6.8 Drug Testing
6.9 HIV/Aids
6.10 Others

7 Global In Vitro Diagnostic Market, By End-User 
7.1 Introduction
7.2 Laboratory
7.3 Hospitals
7.4 Academics
7.5 Point-Of-Care Testing
7.6 Patient Self-Testing
7.7 Others

8 Geographic Analysis 

9 Competitive Landscape 
9.1 Introduction
9.2 New Product Launch
9.3 Agreements, Partnerships, Collaborations & Joint Ventures 
9.4 Mergers And Acquisitions
9.5 Other Developments

10 Company Profiles

Companies Mentioned:

  • Abbott Laboratories, Inc
  • Alere, Inc
  • Arkray, Inc
  • Bayer AG
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc
  • Biomerieux
  • Danaher Corporation
  • Diagnostica Stago Sas
  • Diasorin SPA
  • Hologic, Inc
  • Horiba, Ltd
  • Johnson & Johnson
  • Novartis International Ag
  • Qiagen NV
  • Roche Diagnostics Limited
  • Siemens Healthcare
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc

For more information visit

Media Contact: Laura Wood , +353-1-481-1716,

SOURCE Research and Markets